Annette Langer-Gould to Antibodies, Monoclonal, Humanized
This is a "connection" page, showing publications Annette Langer-Gould has written about Antibodies, Monoclonal, Humanized.
Connection Strength
1.111
-
Early identification of COVID-19 cytokine storm and treatment with anakinra or tocilizumab. Int J Infect Dis. 2020 Oct; 99:291-297.
Score: 0.742
-
Natalizumab use during the third trimester of pregnancy. JAMA Neurol. 2014 Jul 01; 71(7):891-5.
Score: 0.122
-
Progressive multifocal leukoencephalopathy and multiple sclerosis: lessons from natalizumab. Curr Neurol Neurosci Rep. 2006 May; 6(3):253-8.
Score: 0.069
-
What went wrong in the natalizumab trials? Lancet. 2006 Mar 04; 367(9512):708-10.
Score: 0.068
-
Progressive multifocal leukoencephalopathy in a patient treated with natalizumab. N Engl J Med. 2005 Jul 28; 353(4):375-81.
Score: 0.065
-
Monoclonal antibody treatment during pregnancy and/or lactation in women with MS or neuromyelitis optica spectrum disorder. Neurol Neuroimmunol Neuroinflamm. 2020 07 02; 7(4).
Score: 0.045